1Endrizzi B, Ahmed RL,Ray T,et al. Capecitabine to reducenonmelanoma skin carcinoma burden in solid organ transplantrecipients[J].Dermatol Surg, 2013, 39(4):634-645.
2Koeberle D, Burkhard R,von Moos R, et al.Phase IIstudy of capecitabine and oxaliplatin given prior to andconcurrently with preoperative pelvic radiotherapy in patientswith locally advanced rectal cancer[J].Br J Cancer, 2008,98(7):1204-1209.
6Cassidy J,Clarke S, Diaz-Rubio E, et al.Randomizedphase HI study of capecitabine plus oxaliplatin comparedwith fluorouracil/folinic acid plus oxaliplatin as first-linetherapy for metastatic colorectal cancer[J]. J Clin Oncol,2008,26(12):2006-2012.
2Sun YS,Zhang XP,Tang L,et al.Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy:preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.Radiology,2010,254(1):170-178.
3Colorectal Cancer Collaborative Group.Adjuvant radiotherapy for rectal cancer:a systematic overview of 8507 patients from 22 randomised trials.Lancet,2001,358(9290):1291-1304.
5Park IJ,Kim HC,Yu CS,et al.Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.Ann Surg Oncol,2008,15(2):519-525.
6Lebwohl B,Ballas L,Cao Y,et al.Treatment interruption and discontinuation in radiotherapy for rectal cancer.Canaer Invest,2010,28(3):289-294.
7Hoffe SE,Shridhar R,Biagioli MC.Radiation therapy for rectal cancer:current status and future directions.Cancer Control,2010,17(1):25-34.
8NCCN clinical practice guidelines in oncology. Version 2. 2011 [20111-03-10]. http://www, nccn. org.
9Van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorinin patients with metastatic eolorectal cancer : Results of a large Phase III study .J Clin Oncol,2001,19:4097-4106.
10Twelves C, Wong A, Nowacki MP, et al. Capecitabine as Adjuvant Treatment for Stage Ill Colon Cancer. N Eng J Med, 2005,352:2696-2704.
1Nijkamp J, Doodeman B, Marijnen C, et ah Bowel exposure in rectal cancer IMRT using prone, supine, or a belly board[J]. Radiother Oncol, 2012, 102(1): 22.
